We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Controlled-Release Drug Delivery System Heals Spinal Inflammation in Mouse Model

By LabMedica International staff writers
Posted on 06 Jul 2015
Print article
Image: Scanning electron microscope (SEM) image of a field of polypyrrole nanowires (Photo courtesy of Dr. Richard Borgens, Purdue University).
Image: Scanning electron microscope (SEM) image of a field of polypyrrole nanowires (Photo courtesy of Dr. Richard Borgens, Purdue University).
A novel drug delivery system that allows controllable release of an anti-inflammatory agent directly to the site of inflammation or injury was tested successfully in a mouse model.

Investigators at Purdue University (West Lafayette, IN, USA) developed an implantable device comprising polypyrrole nanowires (PpyNWs) loaded with the anti-inflammatory corticosteroid dexamethasone. Polypyrrole is an inert and biocompatible conductive polymer material that responds to an electromagnetic field by releasing the bound drug.

The investigators lifted a one to two square millimeters patch of dexamethasone-doped PpyNWs onto a single drop of sterile water held by surface tension. The drop was deposited onto a spinal cord lesion in a transgenic mouse that produced a luminescent form of glial fibrillary acidic protein (GFAP). This protein is expressed in astrocytes that gather in high numbers at the site of central nervous system injuries where they take part in the inflammatory process and form scar tissue. In this study, the strength of the GFAP luminescent signal was a marker for degree of inflammation.

The corticosteroid dexamethasone, a powerful ameliorator of inflammation, was released from the PpyNWs by external application of an electromagnetic field for two hours per day for a week.

Results published in the May 12, 2015, online edition of the Journal of Controlled Release revealed that the GFAP signal, measured by bioluminescent imaging in the living animal, was significantly reduced in treated animals. At the end of one week, GFAP was at the edge of detection, and in some experimental animals, completely eradicated. Control animals that did not receive a patch or received a patch that did not contain dexamethasone showed no decrease in GFAP signaling.

"This method allows a very, very small dose of a drug to effectively serve as a big dose right where you need it," said senior author Dr. Richard Borgens, professor of applied neuroscience at Purdue University. "By the time the drug diffuses from the site out into the rest of the body, it is in amounts that are undetectable in the usual tests to monitor the concentration of drugs in the bloodstream."

"This tool allows us to apply drugs as needed directly to the site of injury, which could have broad medical applications," said Dr. Borgens. "The technology is in the early stages of testing, but it is our hope that this could one day be used to deliver drugs directly to spinal cord injuries, ulcerations, deep bone injuries or tumors, and avoid the terrible side effects of systemic treatment with steroids or chemotherapy."

Related Links:

Purdue University


Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Hepatitis B Virus Test
HBs Ab – ELISA
New
Thyroxine ELISA
T4 ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.